Cargando…

The Conceptual Framework of Dual Disorders and Its Flaws

When psychiatric illness and substance use disorder coexist, the clinical approach to the patient is, unsurprisingly, awkward. This fact is due to a cultural context and, more directly, to the patient’s psychiatric condition and addiction behaviors—a situation that does not favor a scientific approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacini, Matteo, Maremmani, Angelo G. I., Maremmani, Icro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408800/
https://www.ncbi.nlm.nih.gov/pubmed/32635296
http://dx.doi.org/10.3390/jcm9072098
_version_ 1783567915957616640
author Pacini, Matteo
Maremmani, Angelo G. I.
Maremmani, Icro
author_facet Pacini, Matteo
Maremmani, Angelo G. I.
Maremmani, Icro
author_sort Pacini, Matteo
collection PubMed
description When psychiatric illness and substance use disorder coexist, the clinical approach to the patient is, unsurprisingly, awkward. This fact is due to a cultural context and, more directly, to the patient’s psychiatric condition and addiction behaviors—a situation that does not favor a scientific approach. In dual disorder facilities, several types of professionals work together: counselors, social workers, psychologists, and psychiatrists. Treatment approaches vary from one service to another and even within the same service. It is crucial to provide dual disorder patients with multiple treatments, comprising hospitalization, rehabilitative and residential programs, case management, and counselling. Still, when treating dual disorder (DD) heroin use disorder (HUD) patients, it is advisable to follow a hierarchical algorithm. First, we must deal with addiction: by detoxification, whenever possible. This means starting most patients on anti-craving pharmacological maintenance, though aversion therapy may be appropriate for a few of them. Opiate antagonists may be used with heroin-addicted patients as long as those patients are only mildly ill. In contrast, agonist opioid medications, i.e., buprenorphine and methadone suit moderately and severely ill patients, respectively. Achieving control of mood instability or psychotic episodes is the next step, to be followed by a prevention strategy to counteract residual cravings and dominate mood disorders or psychotic episodes through long-term pharmacological maintenance that is focused on a double target.
format Online
Article
Text
id pubmed-7408800
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74088002020-08-13 The Conceptual Framework of Dual Disorders and Its Flaws Pacini, Matteo Maremmani, Angelo G. I. Maremmani, Icro J Clin Med Commentary When psychiatric illness and substance use disorder coexist, the clinical approach to the patient is, unsurprisingly, awkward. This fact is due to a cultural context and, more directly, to the patient’s psychiatric condition and addiction behaviors—a situation that does not favor a scientific approach. In dual disorder facilities, several types of professionals work together: counselors, social workers, psychologists, and psychiatrists. Treatment approaches vary from one service to another and even within the same service. It is crucial to provide dual disorder patients with multiple treatments, comprising hospitalization, rehabilitative and residential programs, case management, and counselling. Still, when treating dual disorder (DD) heroin use disorder (HUD) patients, it is advisable to follow a hierarchical algorithm. First, we must deal with addiction: by detoxification, whenever possible. This means starting most patients on anti-craving pharmacological maintenance, though aversion therapy may be appropriate for a few of them. Opiate antagonists may be used with heroin-addicted patients as long as those patients are only mildly ill. In contrast, agonist opioid medications, i.e., buprenorphine and methadone suit moderately and severely ill patients, respectively. Achieving control of mood instability or psychotic episodes is the next step, to be followed by a prevention strategy to counteract residual cravings and dominate mood disorders or psychotic episodes through long-term pharmacological maintenance that is focused on a double target. MDPI 2020-07-03 /pmc/articles/PMC7408800/ /pubmed/32635296 http://dx.doi.org/10.3390/jcm9072098 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Pacini, Matteo
Maremmani, Angelo G. I.
Maremmani, Icro
The Conceptual Framework of Dual Disorders and Its Flaws
title The Conceptual Framework of Dual Disorders and Its Flaws
title_full The Conceptual Framework of Dual Disorders and Its Flaws
title_fullStr The Conceptual Framework of Dual Disorders and Its Flaws
title_full_unstemmed The Conceptual Framework of Dual Disorders and Its Flaws
title_short The Conceptual Framework of Dual Disorders and Its Flaws
title_sort conceptual framework of dual disorders and its flaws
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408800/
https://www.ncbi.nlm.nih.gov/pubmed/32635296
http://dx.doi.org/10.3390/jcm9072098
work_keys_str_mv AT pacinimatteo theconceptualframeworkofdualdisordersanditsflaws
AT maremmaniangelogi theconceptualframeworkofdualdisordersanditsflaws
AT maremmaniicro theconceptualframeworkofdualdisordersanditsflaws
AT pacinimatteo conceptualframeworkofdualdisordersanditsflaws
AT maremmaniangelogi conceptualframeworkofdualdisordersanditsflaws
AT maremmaniicro conceptualframeworkofdualdisordersanditsflaws